NCT05157646 The Relationship Between CFTR Gene Mutations and Exercise Capacity Status WITHDRAWN Phase NA
NCT05153317 Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis (CF) Participants 2 Years and Older Status COMPLETED Phase PHASE3
NCT05147285 The Effect of Telerehabilitation on Functional Capacity, Oxidative Stress and Respiratory Parameters in Cystic Fibrosis Status COMPLETED Phase NA
NCT05140967 Effects of Training Intensity on Physical Fitness and Body Composition in Cystic Fibrosis Status COMPLETED Phase NA
NCT05111145 A Study Evaluating the Safety of Elexacaftor/Tezacaftor/Ivacaftor in Participants With Cystic Fibrosis (CF) Status COMPLETED Phase PHASE3
NCT05101915 Study of a Nebulised Nitric Oxide Generating Solution in Patients With Mycobacterium Abscessus Status TERMINATED Phase PHASE2
NCT05100823 Validation of Therapeutic Efficacy Targeting the Splicing Variants in Cystic Fibrosis and CFTR Pathologies Status TERMINATED Phase NA
NCT05099939 Identification of Dysglycemia With Continuous Glucose Monitoring to Assess Clinical Evolution in Cystic Fibrosis Status RECRUITING Phase N/A
NCT05095246 A Study of Inhaled KB407 for the Treatment of Cystic Fibrosis Status WITHDRAWN Phase PHASE1
NCT05090904 A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Brensocatib Tablets in Adults With Cystic Fibrosis Status COMPLETED Phase PHASE2
NCT05088447 A Study to Investigate Cystic Fibrosis Pulmonary Exacerbations and the Lung Microbiome Status TERMINATED Phase N/A
NCT05076149 A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation Status COMPLETED Phase PHASE3
NCT05069597 Study to Evaluate Symptoms of Exocrine Pancreatic Insufficiency in Adult Participants With Cystic Fibrosis or Chronic Pancreatitis Treated With Creon Status COMPLETED Phase PHASE4
NCT05033080 A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF) Status COMPLETED Phase PHASE3
NCT05029817 Ovarian Reserve in Women With Cystic Fibrosis and the Correlation With Demographic and Clinical Parameters Status UNKNOWN Phase N/A
NCT05026918 Manual Chest Physiotherapy and Active Cycle of Breathing Techniques (ACBT) in Patients of Cystic Fibrosis Status COMPLETED Phase NA